Washington, March 26 (NationPress) A coalition of US senators has called upon federal authorities to take action against the unauthorized online distribution of abortion pills, highlighting connections to international supply networks, particularly from India. In a letter addressed to FDA Commissioner Martin Makary on Wednesday, these lawmakers demanded “swift action” to prevent “misbranded and unapproved versions of the chemical abortion medications, mifepristone and misoprostol” from entering the US market.

They stated that the “illicit sale of these pharmaceuticals jeopardizes women’s health and undermines the FDA’s fundamental responsibility to safeguard American consumers.”

The senators expressed concerns that unrestricted online access without medical oversight “poses significant risks to women’s health and increases the likelihood of compelled and coerced abortions.”

The correspondence highlights the global supply chains involved, indicating that drugs offered on foreign websites “often originate from various manufacturers in India.”

Lawmakers pointed out the rapid expansion of the online market, citing one provider that dispatched 43,259 packages to 30 US states within a year, while another estimate suggested that “up to 100,000 packages” were shipped into the US in 2023.

The senators identified four primary channels for these sales: US-based telehealth clinics, foreign clinics, informal networks, and online pharmacies. Many of these entities operate without prescriptions or adequate oversight.

They warned that some websites falsely advertise “FDA-approved” drugs, when in reality, they dispatch unapproved versions from overseas producers.

The letter also raised safety concerns, noting that some platforms instruct users not to disclose to their doctors that they have taken these medications.

The lawmakers urged the FDA to enhance its enforcement efforts, including issuing warning letters, taking action against website domains, and improving collaboration with customs and postal services to intercept shipments.

They also called for criminal investigations, referencing a 2020 case in which a US resident was prosecuted for selling abortion pills sourced from India without prescriptions.

The senators insisted that the FDA must “fully utilize its authorities” and prioritize this pressing issue.

Led by Senator Bill Cassidy, the letter was co-signed by Senators Steve Daines, James Lankford, Cindy Hyde-Smith, and Lindsey Graham. They have requested a response from the FDA detailing enforcement measures by April 8.

Medication abortion is prevalent in the US, typically involving mifepristone followed by misoprostol under regulated conditions.